1-2 of 2
Suthat Fuchareon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 2 trial of HQK-1001 in HbE-β thalassemia demonstrates HbF induction and reduced anemia

Clinical Trials & Observations
Poramin Patthamalai, Suthat Fuchareon, Nattawara Chaneiam, Richard G. Ghalie, David H. K. Chui, Michael S. Boosalis, Susan P. Perrine
Journal: Blood
Blood (2014) 123 (12): 1956–1957.
https://doi.org/10.1182/blood-2013-11-538470
Published: 2014
Journal Articles

HQK-1001 Is Well Tolerated and Augments Hemoglobin F and Hemoglobin Levels In Patients with Beta Thalassemia Intermedia

Suthat Fuchareon, MD, Adlette C. Inati, MD, Noppadol Siritanaratkul, MD, Suzanne Koussa, MD, Ali Taher, MD, Michael S Boosalis, PhD, Swee Lay Thein, DSc, FRCP, MB, BS, FRCPath, Wayne Wallis, MD, Patrick Bobbitt, BS, Audrey Thomson, BSc, Elsa Johnson, MBA, Ronald J Berenson, MD, Susan P Perrine, MD
Journal: Blood
Blood (2010) 116 (21): 4280.
https://doi.org/10.1182/blood.V116.21.4280.4280
Published: 2010